Stockscreener 앱 받기
6.00
3.54%
-0.22
전일 마감가:
$6.22
열려 있는:
$6.15
하루 거래량:
254.31K
Relative Volume:
1.09
시가총액:
$44.68M
수익:
-
순이익/손실:
$-22.06M
주가수익비율:
-1.1347
EPS:
-5.2876
순현금흐름:
$-17.93M
1주 성능:
-22.08%
1개월 성능:
+21.95%
6개월 성능:
+63.04%
1년 성능:
+38.25%
1일 변동 폭
$5.86
$6.52
1주일 범위
$5.86
$7.92
52주 변동 폭
$3.20
$7.92
Cingulate Inc Stock (CING) Company Profile
명칭
Cingulate Inc
전화
(913) 942-2300
주소
1901 W. 47TH PLACE, KANSAS CITY
Compare CING vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
6.00 | 46.32M | 0 | -22.06M | -17.93M | -5.2876 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | ROTH MKM | Buy |
| 2023-12-22 | 다운그레이드 | Laidlaw | Buy → Hold |
Cingulate Inc 주식(CING)의 최신 뉴스
What are analysts’ price targets for Cingulate Inc. Equity WarrantMarket Performance Report & Safe Capital Growth Trade Ideas - mfd.ru
Peter Werth Purchases 19,455 Shares of Cingulate (NASDAQ:CING) Stock - MarketBeat
Shane Schaffer Buys 6,809 Shares of Cingulate (NASDAQ:CING) Stock - MarketBeat
Cingulate (NASDAQ:CING) CFO Jennifer Callahan Purchases 4,864 Shares - MarketBeat
Aug Technicals: Will DigitalOcean Holdings Inc outperform small cap indexes2025 EndofYear Setup & High Conviction Buy Zone Picks - baoquankhu1.vn
Growth Value: Is Cingulate Inc likely to announce a buybackWeekly Market Outlook & AI Powered Market Entry Ideas - baoquankhu1.vn
Weekly Recap: Is CDROW stock a good dividend stockWeekly Trading Summary & Safe Capital Growth Plans - baoquankhu1.vn
Cingulate Advances Capital Raise with Private Placement Financing - TipRanks
Macro Review: What are analysts price targets for Cingulate Inc Equity Warrant2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
ADHD Drug Maker Cingulate Draws Investor Attention; Stock Up Over 60% In Seven Months - RTTNews
Ideas Watch: Is Cingulate Inc in a long term uptrendQuarterly Investment Review & Weekly Momentum Picks - baoquankhu1.vn
Sentiment Watch: Should I average down on Cineverse Corp stockTrade Exit Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Cingulate Announces Private Placement and New Preferred Stock - The Globe and Mail
Cingulate Signs Multiple Material Agreements - TradingView
Cingulate Inc. announced that it expects to receive $12.011001 million in funding - marketscreener.com
What’s Cingulate Inc.’s historical returnTrading Volume Surges & The Smart Money Is Buying These Picks - bollywoodhelpline.com
Aug Patterns: What is the target price for Cingulate Inc Equity Warrant stockJuly 2025 Technicals & Community Verified Watchlist Alerts - baoquankhu1.vn
Is Cingulate Inc. stock attractive after correctionJuly 2025 Action & Accurate Buy Signal Alerts - bollywoodhelpline.com
Market Pulse: What is the target price for Cingulate Inc Equity Warrant stockExit Point & Short-Term Trading Alerts - baoquankhu1.vn
Cingulate (NASDAQ:CING) Trading 3.1% Higher – Should You Buy? - Defense World
Cingulate Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Cingulate increases at-the-market offering limit to $31.9 million By Investing.com - Investing.com Canada
Cingulate increases at-the-market offering limit to $31.9 million - Investing.com
Cingulate Inc. Increases Offering Price Under Sales Agreement - TradingView
Quarterly Recap: Is Cingulate Inc likely to announce a buybackJuly 2025 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
Analysis Recap: Why Cingulate Inc stock appeals to analystsForecast Cut & Real-Time Sentiment Analysis - Bộ Nội Vụ
Market Outlook: Will Cingulate Inc Equity Warrant stock remain a Wall Street favoriteJuly 2025 Reactions & High Win Rate Trade Alerts - Bộ Nội Vụ
Cingulate Inc Files For Mixed Shelf Offering Of Up To $200 Million- SEC Filing - TradingView — Track All Markets
Cingulate Retail Buzz Rises After FDA Greenlights Summer NDA Filing For ADHD Drug - MSN
Cingulate price target lowered to $16 from $17 at Roth Capital - MSN
Will Cingulate Inc. stock maintain dividend yieldColor and Style Update & trail grip notes for mixed terrain - ulpravda.ru
Why Cingulate Inc. stock remains a top recommendation2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - Улправда
What analyst consensus says on Cingulate Inc. stockTake Profit & Safe Entry Zone Tips - Улправда
Market Moves: Will Cingulate Inc. stock gain from lower inflationBond Market & Daily Entry Point Trade Alerts - ulpravda.ru
Profit Recap: Is Cingulate Inc. Equity Warrant stock affected by interest rate hikesJuly 2025 Opening Moves & Fast Momentum Stock Entry Tips - Улправда
Is Cingulate Inc. stock oversold or undervaluedQuarterly Trade Review & Low Drawdown Investment Ideas - Улправда
How rising interest rates impact Cingulate Inc. Equity Warrant stockJuly 2025 Summary & Verified Technical Trade Signals - Улправда
Is Cingulate Inc. Equity Warrant stock affected by interest rate hikesWeekly Gains Report & Reliable Price Breakout Signals - Улправда
Is Cingulate Inc. Equity Warrant stock trading at a premium valuation2025 Big Picture & Community Supported Trade Ideas - Улправда
Will Cingulate Inc. Equity Warrant stock gain from lower inflationMarket Risk Summary & High Accuracy Investment Signals - Улправда
How geopolitical tensions affect Cingulate Inc. stockQuarterly Market Review & Long-Term Capital Growth Strategies - Улправда
Will Cingulate Inc. stock continue dividend increasesStock Rotation Strategies & Free High Yield Growth Strategies - Улправда
Crypto: Cingulate, Inc.: The Secret Behind a Stunning 79.64% Surge – Hidden Patterns Revealed - InteractiveCrypto
Cingulate CEO cleared of charges, retains board confidence - MSN
Cingulate continues stock-for-debt exchanges to reduce liabilities - The Globe and Mail
Can Cingulate Inc stock weather global recessionQuarterly Profit Review & Growth Focused Entry Point Reports - Bộ Nội Vụ
Cingulate Inc Equity Warrant Stock Analysis and ForecastMarket Rumors and News & Low Risk Investment Tips - earlytimes.in
Trend Review: Is Cingulate Inc Equity Warrant stock affected by interest rate hikes2025 Big Picture & Low Drawdown Trading Techniques - moha.gov.vn
What technical charts say about Cingulate Inc. Equity Warrant stockMACD Histogram Signals & Minimize Portfolio Damage with Warnings - bollywoodhelpline.com
Cingulate Inc. (NASDAQ:CING) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Why Cingulate Inc stock remains a top recommendation2025 Market Trends & Step-by-Step Trade Execution Guides - moha.gov.vn
Cingulate Inc (CING) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cingulate Inc 주식 (CING) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Callahan Jennifer L. | SVP and CFO |
Feb 06 '26 |
Buy |
5.04 |
4,864 |
24,515 |
5,059 |
| Schaffer Shane J. | Chief Executive Officer |
Feb 06 '26 |
Buy |
5.04 |
6,809 |
34,317 |
10,175 |
| Brams Matthew | EVP and Chief Medical Officer |
Feb 06 '26 |
Buy |
5.04 |
1,946 |
9,808 |
4,656 |
1.12%
0.87%
자본화:
|
볼륨(24시간):